To confirm these in vivo results, dose-dependent effects of ZOL on the expression of CLU mRNA and protein levels were evaluated in a panel of human osteosarcoma cell lines (MNNG/HOS, MG63 and SaOS2). The gene discussed is CLU; the disease is osteosarcoma.